Data / Drug companies / Fludeoxyglucose f-18
Fludeoxyglucose f-18: 13 companies and 14 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Fludeoxyglucose f-18 is listed in the FDA National Drug Code Directory by 13 companies, with 14 products in commercial distribution. 14 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection; injection, solution, and the newest product started marketing on March 11, 2025.
The request: Get every company that lists fludeoxyglucose f-18 in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 13
- Products
- 14
- Generic (ANDA) products
- 14 (100.0%)
- Application numbers
- 14
- Routes
- Intravenous
- Brand names
- Fludeoxyglucose F 18, Fludeoxyglucose F 18, Fludeoxyglucose F18
- openFDA record search
- api.fda.gov
Companies that list fludeoxyglucose f-18
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Biomedical Research Foundation of Northwest Louisiana | 2 | injection, solution | Generic drugs (ANDA) | May 14, 2015 |
| Bamf Health Inc. | 1 | injection | Generic drugs (ANDA) | March 11, 2025 |
| Barbara Ann Karmanos Cancer Hospital | 1 | injection | Generic drugs (ANDA) | January 31, 2020 |
| Brigham and Women's Hospital, Inc., The | 1 | injection | Generic drugs (ANDA) | October 30, 2014 |
| Cardinal Health 414, LLC | 1 | injection | Generic drugs (ANDA) | January 2, 2019 |
| Jubilant DraxImage Inc., DBA Jubilant Radiopharma | 1 | injection, solution | Generic drugs (ANDA) | November 20, 2010 |
| Kettering Medical Center | 1 | injection | Generic drugs (ANDA) | December 8, 2011 |
| Massachusetts General Hospital | 1 | injection, solution | Generic drugs (ANDA) | October 30, 2011 |
| Mayo Clinic | 1 | injection | Generic drugs (ANDA) | August 5, 2013 |
| Precision Nuclear LLC | 1 | injection, solution | Generic drugs (ANDA) | October 10, 2010 |
| Sofie Co. | 1 | injection | Generic drugs (ANDA) | December 8, 2011 |
| Trustees of the University of Pennsylvania | 1 | injection, solution | Generic drugs (ANDA) | October 30, 2014 |
| Uihc-P E T Imaging Center | 1 | injection | Generic drugs (ANDA) | December 12, 2011 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection | 8 | 57.1% |
| Injection, solution | 6 | 42.9% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 14 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Radioactive Diagnostic Agent | 14 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.